Africa's urban middle class is attracting pharmaceutical firms.
Analysts say pharmaceutical spending will rise to $30 billion by 2016.
The continent is expected to experience a rise in demand for chronic disease treatments.
Lack of infrastructure, varied regulations and counterfeit drugs are challenges.
